🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Pancreatic Carcinoma

Access to Genetic Testing in Underserved Patients With Cancer NCT06422455NA2 sites📍 Los Angeles📍 Rochester University of Southern California · Tests: Best Practice, Educational Intervention, Electronic Health Record Review, Genetic Counseling, Interview GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care NCT05391126NA1 site📍 Lexington Reema A. Patel · Tests: Irinotecan Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP NCT05268692Phase 2, Phase 31 site📍 Kochi Kochi University · Tests: GS, GnP VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma NCT03556228Phase 1, Phase 215 sites📍 Santa Rosa📍 Hartford📍 Washington D.C. VM Oncology, LLC · Tests: VMD-928 100 mg Tablet, VMD-928 Tablet and Pembrolizumab (200 mg) Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors NCT06821048Phase 11 site📍 Hangzhou Weijia Fang, MD · Tests: Intraperitoneal infusion of FAST CEA-targeted CAR-T Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel NCT06483555Phase 1, Phase 21 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: Gemcitabine, Nab paclitaxel, Erlotinib, NALIRIFOX, Folfirinox A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites📍 Los Angeles📍 Grand Rapids📍 Columbus Tanabe Pharma America, Inc. · Tests: MT-4561 Comparing Laparoscopic and Open Surgery for Pancreatic Carcinoma NCT03785743NA1 site📍 Wuhan Tongji Hospital · Tests: TLPD Surgery, OPD Surgery Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer NCT07539155Phase 1, Phase 21 site📍 Little Rock University of Arkansas · Tests: Intratumoral MMR Injection Advanced Therapies for Liver Metastases NCT04622423n/a1 site📍 Milan IRCCS San Raffaele 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors NCT07557225NA1 site📍 Beijing Peking University First Hospital · Tests: 18F-T2 PET/CT The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer NCT06368063Phase 41 site📍 Xi'an Xi'an Jiaotong University · Tests: Huaier granule, chemotherapy drugs A Phase II Study of GFH375 Combined With GFS202A or GFH276 Versus GFH375 in Patients With Previously Treated Locally Advanced Unresectable or Metastatic Pancreatic Cancer Harboring KRAS G12D Mutation NCT07784374Phase 21 site📍 Shanghai Genfleet Therapeutics (Shanghai) Inc. · Tests: GFH375, GFH276, GFS202A A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors NCT05932862Phase 116 sites📍 Fountain Valley📍 Jacksonville📍 Orlando Exelixis · Tests: XL309, Olaparib AB122 Platform Study NCT04999761Phase 19 sites📍 Aichi📍 Chiba📍 Ehime Taiho Pharmaceutical Co., Ltd. · Tests: AB122, AB122, TAS-116, TAS-120, TAS-115 IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer NCT07692750Phase 1, Phase 21 site📍 Hangzhou Zhejiang Cancer Hospital · Tests: IBI343+ capecitabine, IBI343+Capecitabine+oxaliplatin Ablative Carbon Ion Radiotherapy With Pencil Beam Scanning for Locally Advanced Unresectable Pancreatic Cancer NCT05424159NA1 site📍 Shanghai Shanghai Proton and Heavy Ion Center · Tests: Carbon ion radiotherapy Surveillance of Pancreatic Health After Diabetes Diagnosis NCT06803771NA31 sites📍 Sandbach📍 Maidstone📍 Leicester University Hospital Southampton NHS Foundation Trust · Tests: Avantect Pancreatic Cancer Test Artificial Intelligence in Endoscopic Ultrasound NCT06564571n/a1 site📍 Orlando Orlando Health, Inc. · Tests: Patients undergoing endoscopic ultrasound procedures ctDNA Assay in Patients With Resectable Pancreatic Cancer NCT05052671n/a2 sites📍 Oklahoma City📍 Tulsa University of Oklahoma A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02) NCT06330064Phase 1, Phase 2120 sites📍 Los Angeles📍 Los Angeles📍 Whittier Daiichi Sankyo · Tests: Ifinatamab deruxtecan Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer NCT07429487NA1 site📍 Nice Centre Antoine Lacassagne · Tests: APA program PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC) NCT06673017Phase 19 sites📍 Newport Beach📍 Miami📍 Detroit PanTher Therapeutics · Tests: PTM-101 A Phase I Clinical Study of IX001 TCR-T Injection in the Treatment of Advanced Pancreatic Cancer Patients With KRAS G12V Mutation NCT06898385Phase 11 site📍 Guangzhou Sun Yat-sen University · Tests: IX001 TCR-T injection, Fludarabine, Cyclophosphamide A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors NCT06131840Phase 148 sites📍 Phoenix📍 Scottsdale📍 Duarte Seagen, a wholly owned subsidiary of Pfizer · Tests: PF-08046050, bevacizumab, 5-Fluorouracil (5-FU), Oxaliplatin, Leucovorin (LV) A Study of LY4337713 in Participants With FAP-Positive Solid Tumors NCT07213791Phase 130 sites📍 Newport Beach📍 Stanford📍 Miami Eli Lilly and Company · Tests: LY4337713 Intraductal Papillary Mucinous Neoplasm (IPMN) Database - A Tool to Predict Pancreatic Cancer NCT05117723n/a1 site📍 Fitzroy St Vincent's Hospital Melbourne Discovery of Soluble Biomarkers for Pancreatic Cancer Using Innovative All-Patient Inclusive Methodology NCT04370574n/a1 site📍 Montpellier University Hospital, Montpellier · Tests: Soluble Biomarkers dosage Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals NCT06122896EARLY Phase 12 sites📍 Boston📍 Boston Dana-Farber Cancer Institute · Tests: Screening Blood Tests, Endoscopic Ultrasound, Magnetic Resonance Imaging, Magnetic Resonance Cholangiopancreatography Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer NCT06782932Phase 1, Phase 21 site📍 Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Tests: AGEN2373, Balstilimab, Cyclophosphamide, GVAX, AGEN2373 (RP2D)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy